Drug profile · INN
vonoprazan fumarate
TAKECAB
vonoprazan fumarate (TAKECAB) is a potassium-transporting atpase inhibitor. Associated with Phathom Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
Drug details — vonoprazan fumarate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 8
- Programs
- 17
- Data quality
- 0.89
Quick answer
vonoprazan fumarate (TAKECAB) is a potassium-transporting atpase inhibitor. Associated with Phathom Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Potassium-transporting ATPase inhibitor
Primary target: Potassium-transporting ATPase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 9198961
Bacterial extract for digestive or urinary tract disorders and process for its preparation
granted -
US 9186411
Pharmaceutical composition
granted -
US 9017743
Bacterial extract for digestive or urinary tract disorders and process for its preparation
granted -
US 8236522
Bacterial extract for digestive or urinary tract disorders and process for its preparation
granted -
US 8173133
Acyl pseudodipeptides which carry a functionalized auxiliary arm
granted -
US 7977488
1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
granted -
US 7799762
Acyl pseudodipeptides which carry a functionalised auxialiary arm
granted -
US 7157092
Acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same
granted
Frequently asked questions
What is vonoprazan fumarate?
vonoprazan fumarate (TAKECAB) is a potassium-transporting atpase inhibitor. Associated with Phathom Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for vonoprazan fumarate?
TAKECAB is a marketed brand name for vonoprazan fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vonoprazan fumarate?
vonoprazan fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.